|
|
|
|
|
by Majromax
1943 days ago
|
|
> at what point do you budge? Around the same time that you dispense with phase 3 trials entirely. It was more likely than not that the Pfizer/Moderna vaccines were effective by the time they'd completed phase 2 studies. If that is our standard, then we ought to have begun vaccinating at-risk individuals on a volunteer basis then -- in Fall of 2020. To me, it's inconsistent to both say we need a full phase 3 clinical trial to grant authorization to a vaccine, but then to ignore the protocol of that phase 3 trial when distributing it. |
|
Regardless, the real solution should have been early human challenge trials and we would have had the vaccine already in the beginning of the summer most likely.